Hong Kong Pharma Digital Technology Holdings Limited
HKPD · NASDAQ
3/31/2025 | 3/31/2024 | 3/31/2023 | |
|---|---|---|---|
| Valuation | |||
| PEG Ratio | 3.55 | 0.16 | 0.00 |
| FCF Yield | 4.25% | -2.32% | 5.19% |
| EV / EBITDA | 9.42 | 8.77 | 17.73 |
| Quality | |||
| ROIC | -1.34% | 22.10% | 79.97% |
| Gross Margin | 11.89% | 21.32% | 21.81% |
| Cash Conversion Ratio | -21.04 | -0.30 | 1.73 |
| Growth | |||
| Revenue 3-Year CAGR | 17.39% | 2,555,372.75% | 2,324,154.42% |
| Free Cash Flow Growth | 185.88% | -129.97% | 0.00% |
| Safety | |||
| Net Debt / EBITDA | 1.35 | 0.58 | 0.09 |
| Interest Coverage | 1.35 | 19.43 | 44.91 |
| Efficiency | |||
| Inventory Turnover | 31.96 | 14.07 | 51.43 |
| Cash Conversion Cycle | 60.87 | 70.50 | 4.38 |